Purdue Pharma owners up opioid settlement offer to $6 bn

The owners of Purdue Pharma, maker of OxyContin, have offered to pay up to $6 billion to victims of the US opioid crisis to settle an avalanche of litigation, according to a report filed Friday by a federal mediator.

The Sackler family’s new offer would raise by at least a billion dollars a $4.5 billion bankruptcy settlement thrown out by a US in December over language that would have shielded the family from further lawsuits involving the highly addictive prescription painkiller.

Under the new proposal, the Sacklers “would be paying, in total, not less than $5.5 billion and up to $6 billion”, according to Friday’s filing to the US Bankruptcy Court in the Southern District of New York.

But while a “supermajority” of involved parties have agreed to the deal, all eight US states involved along with the District of Columbia would need to sign off for it to move forward, the report filed by US Bankruptcy Court Judge Shelley Chapman states.

The additional funds would be used “exclusively for abatement of the opioid crisis, including support and services for survivors, victims, and their families”, according to the report.

The opioid addiction crisis has caused more than 500,000 overdose deaths in the United States over the past 20 years.

Facing thousands of lawsuits, Purdue filed for bankruptcy in 2019, and it pled guilty to three over its aggressive marketing of OxyContin in 2020.

In December, US Judge Colleen McMahon ruled that the who approved the original plan three months earlier had no authority to prevent future lawsuits against the Sacklers, except in cases of intentional misconduct.

While more than 40 states had signed off on the rejected deal, a group of eight, along with the District of Columbia, refused to accept it.

William Tong, the Connecticut attorney general who led the appeal against the earlier ruling, called its overturning a “seismic victory for justice and accountability”.



© 2022 AFP

Citation:
Purdue Pharma owners up opioid settlement offer to $6 bn (2022, February 20)
retrieved 8 March 2022
from https://medicalxpress.com/news/2022-02-purdue-pharma-owners-opioid-settlement.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Kids With COVID-Linked MIS-C Have Long-Term Symptoms thumbnail

Kids With COVID-Linked MIS-C Have Long-Term Symptoms

By Steven Reinberg HealthDay Reporter THURSDAY, Feb. 3, 2022 (HealthDay News) -- Following a bout of severe COVID-19, some children suffer lasting neurological complications, part of a rare condition called multisystem inflammatory syndrome in children (MIS-C), a new study finds. The neurological symptoms are wide-ranging, and can include headaches, difficulty falling and staying asleep, daytime…
Read More
UK finds rise in non-compliant products from the U.S. thumbnail

UK finds rise in non-compliant products from the U.S.

Authorities in the United Kingdom have issued a warning because of a rise in the number of non-compliant food and drink products being imported from countries including the United States. The problem was identified by the Food Standards Agency (FSA) through import surveillance sampling and the occurrence of incidents. Local authorities have been asked to…
Read More
מחקר ענק: החיסון של מודרנה יעיל מזה של פייזר במניעת הדבקה thumbnail

מחקר ענק: החיסון של מודרנה יעיל מזה של פייזר במניעת הדבקה

במחקר חדש שבדק את ההבדלים ביעילות בין חיסוני מודרנה ופייזר לקורונה, נמצא שאנשים שקיבלו שתי מנות מתרכיב החיסון של חברת מודרנה נטו פחות להידבק בקורונה או להתאשפז מאשר אנשים שקיבלו את החיסון של חברת פייזר. המחקר בוצע על ידי חוקרים מבית הספר לרפואה בקליבלנד אוהיו ופורסם לאחרונה כמכתב-מחקר בכתב העת JAMA. שני החיסונים הם חיסוני…
Read More
Video: How irritable bowel syndrome affects you thumbnail

Video: How irritable bowel syndrome affects you

IBS is a functional disorder. Even though the digestive tract looks normal, it doesn't function as it should. Muscles in the intestines move food from the stomach to the rectum. Normally, they contract and relax in a gentle rhythm that moves the food along in a fairly predictable schedule. But with some people, the muscles
Read More
'This Is a Good News Story': What We Heard This Week thumbnail

‘This Is a Good News Story’: What We Heard This Week

Opinion > What We Heard This Week — Quotable quotes heard by MedPage Today's reporters by MedPage Today Staff May 14, 2023 "This is a good news story." -- Carol Mangione, MD, immediate past chair of the U.S. Preventive Services Task Force, on new draft guidance from the influential panel recommending biennial mammography screening starting
Read More
After Years of Sleepless Nights, an Insomnia Diagnosis thumbnail

After Years of Sleepless Nights, an Insomnia Diagnosis

Please enable cookies. Error 1005 Ray ID: 88cdb7f90ff385c9 • 2024-06-01 08:08:56 UTC What happened? The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 88cdb7f90ff385c9 • Your IP: 185.124.111.116 •
Read More
Index Of News
Total
0
Share